FDA Inspection 1333606 — Nami Yamashita, MD, PhD
The FDA completed an inspection of Nami Yamashita, MD, PhD on Aug 10, 2026 in Koto. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 10, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Koto (Japan)
Additional Details
Clinical Investigator (CI)